Phenylpropanolamine and other over-the-counter vasoactive compounds.
- 1 March 1988
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 11 (3_pt_2) , II7-10
- https://doi.org/10.1161/01.hyp.11.3_pt_2.ii7
Abstract
Phenylpropanolamine is a sympathomimetic amine that shares structural similarities with amphetamine and ephedrine. It increases blood pressure primarily by increasing peripheral vascular resistance. This effect is the result of alpha-adrenergic agonist activity largely from both direct stimulation of adrenergic receptors and release of neuronal norepinephrine. As such, it has the potential to interact with other drugs to produce toxic reactions, especially in treated hypertensive patients. Complications have occurred with single oral doses that suggest some normal subjects may be more sensitive to the drug than others. The incidence of serious complications in the general population is small but could be much higher in susceptible individuals (e.g., cardiomyopathic and hypertensive patients). The availability of high-dose phenylpropanolamine-containing preparations without medical supervision is potentially dangerous, and certain restrictions should be imposed on such preparations.Keywords
This publication has 17 references indexed in Scilit:
- STROKE AND PHENYLPROPANOLAMINE USEThe Lancet, 1983
- Phenylpropanolamine: A potentially hazardous drugAnnals of Emergency Medicine, 1982
- Myocardial injury after phenylpropanolamine ingestion.Heart, 1982
- Amphetamine-like Reactions to PhenylpropanolaminePublished by American Medical Association (AMA) ,1981
- Psychotic reaction caused by proprietary oral diet agentsAmerican Journal of Psychiatry, 1980
- HYPERTENSIVE RESPONSES INDUCED BY PHENYLPROPANOLAMINE IN ANORECTIC AND DECONGESTANT PREPARATIONSThe Lancet, 1980
- PHENYLPROPANOLAMINE AND MENTAL DISTURBANCESThe Lancet, 1979
- SEVERE HYPERTENSION AFTER INGESTION OF AN APPETITE SUPPRESSANT (PHENYLPROPANOLAMINE) WITH INDOMETHACINThe Lancet, 1979
- Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol.BMJ, 1976
- Cough and Cold Remedies: a Potential Danger to Patients on Monoamine Oxidase InhibitorsBMJ, 1969